Answers are grounded in this paper and cite their sources.
In this work, a luminol-centric biosensor was constructed for the ultrasensitive detection of tryptase (TPS) combining dissolved O 2 as the endogenous coreactant and Au–Ag–Pt heteronanostructures (AAPHNs) as coreaction accelerator. Dissolved O 2 could rapidly generate superoxide anion radical (O 2 •– ) with the catalysis of AAPHNs to in situ react with luminol anion radical (L •– ) to generate excited-state species 3-aminophthalate (AP 2–* ) for emitting ECL signal, resulting in a remarkable “single on” state. In order to further improve the sensitivity of the sensor, we employed self-assembled DNA nanotubes (DNANTs) as a carrier to immobilize the luminophore of doxorubicin-luminol (Dox-Lu) complex. In this assay system, target tryptase could directly induce the cleavage of vasoactive intestinal peptide (VIP), which caused the ECL probe of DNANTs-Dox-Lu releasing from the electrode surface to obtain a significant “signal off” state. By changing the signal from “on” to “off”, the proposed ECL peptide-based biosensor for TPS detection achieved a dynamic concentration range (2.5 pg/mL–200 ng/mL) with an extremely low detection limit of 0.81 pg/mL. This work presented a new signal amplification method for the construction of the sensor based on the luminol-dissolved O 2 ECL system.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: